S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Power Play: GE's game-changing technology for EVs and grids
Home sales hit a 13-year low... what now?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Stock market today: Wall Street takes a breather after best trading month of the year
Salesforce.com completes a reversal: new all-time high in sight
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
A 15% gain in store for Five Below after rosy holiday outlook
Elon Musk Gives Profanity-Laden Tirade During DealBook Interview: "Go F--- Yourself'
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Power Play: GE's game-changing technology for EVs and grids
Home sales hit a 13-year low... what now?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Stock market today: Wall Street takes a breather after best trading month of the year
Salesforce.com completes a reversal: new all-time high in sight
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
A 15% gain in store for Five Below after rosy holiday outlook
Elon Musk Gives Profanity-Laden Tirade During DealBook Interview: "Go F--- Yourself'
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Power Play: GE's game-changing technology for EVs and grids
Home sales hit a 13-year low... what now?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Stock market today: Wall Street takes a breather after best trading month of the year
Salesforce.com completes a reversal: new all-time high in sight
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
A 15% gain in store for Five Below after rosy holiday outlook
Elon Musk Gives Profanity-Laden Tirade During DealBook Interview: "Go F--- Yourself'
S&P 500   4,567.80
DOW   35,950.89
QQQ   388.83
Are blue chip stocks a good investment?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Power Play: GE's game-changing technology for EVs and grids
Home sales hit a 13-year low... what now?
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
Stock market today: Wall Street takes a breather after best trading month of the year
Salesforce.com completes a reversal: new all-time high in sight
The Only Practical Solution to the World’s Looming Energy Crisis (Ad)
A 15% gain in store for Five Below after rosy holiday outlook
Elon Musk Gives Profanity-Laden Tirade During DealBook Interview: "Go F--- Yourself'

Ion Beam Applications Stock Price, News & Analysis (OTCMKTS:IOBCF)

$11.50
0.00 (0.00%)
(As of 11/30/2023 ET)
Compare
Today's Range
$11.50
$11.50
50-Day Range
$8.65
$11.50
52-Week Range
$8.65
$20.00
Volume
N/A
Average Volume
508 shs
Market Capitalization
N/A
P/E Ratio
135.67
Dividend Yield
N/A
Price Target
N/A

IOBCF stock logo

About Ion Beam Applications Stock (OTCMKTS:IOBCF)

Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. This segment also offers turnkey solutions for the treatment of cancer through the use of proton beams; and a line of cyclotrons used for the production of positron emission tomography or SPECT radioisotopes, as well as a line of industrial accelerators for sterilization and ionization. The Dosimetry segment provides solutions and services that enhances efficiency and minimizes errors in radiation therapy and medical imaging quality assurance and calibration procedures. The company has strategic research and development partnership with SCK CEN (Belgian nuclear research center) to enable the production of Actinimum-225 (225Ac), a novel radioisotope for the treatment of cancer; and an agreement with University of Pennsylvania for research in ConformalFLASH. It also has a research partnership with Particle Therapy Interuniversity Center Leuven for the development of ConformalFLASH1. Ion Beam Applications SA was incorporated in 1986 and is headquartered in Louvain-la-Neuve, Belgium.

IOBCF Stock Price History

IOBCF Stock News Headlines

IBA SA: IBA Business Update - Third Quarter 2023
IBA Business Update – Third Quarter 2023
The Only Practical Solution to the World’s Looming Energy Crisis
There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!
IBA SA: IBA Reports Half Year 2023 Results
IBA Reports Half Year 2023 Results
The Only Practical Solution to the World’s Looming Energy Crisis
There’s just one problem: There are more plans for new uses of nuclear than there is uranium to fuel the plants!
IBA SA: IBA Business Update - First Quarter 2023
IBA Business Update – First Quarter 2023
See More Headlines
Receive IOBCF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ion Beam Applications and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Medical Devices
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:IOBCF
CIK
N/A
Fax
N/A
Employees
2,000
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Pierre Mottet (Age 61)
    Chairman of The Board
    Comp: $57.53k
  • Mr. Olivier Legrain (Age 55)
    CEO, President, MD & Executive Director
    Comp: $964.3k
  • Mr. Yves Jongen (Age 76)
    Founder, Chief Research Officer, MD & Executive Director
    Comp: $632.18k
  • Ms. Soumya Chandramouli (Age 44)
    Chief Financial Officer
  • Mr. Frederic Nolf (Age 50)
    Chief Human Resources & Sustainability Officer
  • Marc Van der Burght
    Chief Operation Officer
  • Olivier Lechien
    Corporate Communication Director
  • Thomas Canon
    Sustainability Program Director
  • Bruno Scutnaire
    President of IBA RadioPharma Solutions














IOBCF Stock Analysis - Frequently Asked Questions

How have IOBCF shares performed in 2023?

Ion Beam Applications' stock was trading at $16.78 at the start of the year. Since then, IOBCF shares have decreased by 31.5% and is now trading at $11.50.
View the best growth stocks for 2023 here
.

Are investors shorting Ion Beam Applications?

Ion Beam Applications saw a decrease in short interest during the month of November. As of November 15th, there was short interest totaling 4,800 shares, a decrease of 11.1% from the October 31st total of 5,400 shares. Based on an average trading volume of 100 shares, the days-to-cover ratio is presently 48.0 days.
View Ion Beam Applications' Short Interest
.

How do I buy shares of Ion Beam Applications?

Shares of IOBCF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:IOBCF) was last updated on 12/1/2023 by MarketBeat.com Staff

My Account -